{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:11:12Z","timestamp":1779923472955,"version":"3.53.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12325-022-02158-6","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T15:05:18Z","timestamp":1652281518000},"page":"3146-3158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety and Effectiveness Using 8 Weeks of Glecaprevir\/Pibrentasvir in HCV-Infected Treatment-Na\u00efve Patients with Compensated Cirrhosis: The CREST Study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-8001","authenticated-orcid":false,"given":"Markus","family":"Cornberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Ahumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Aghemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Andreoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhi","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Butrymowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Carmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"H\u00fcppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jorquera","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Lampertico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa Manzano","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Myles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Persico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alnoor","family":"Ramji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sarrazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Isidro Uriz","family":"Otano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The CREST Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"2158_CR1","unstructured":"World Health Organization (WHO). Hepatitis C fact sheet. 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. Cited 04 Oct 2021"},{"issue":"2","key":"2158_CR2","first-page":"161","volume":"2017","author":"Polaris Observatory, H. C. V. Collaborators","year":"2015","unstructured":"Polaris Observatory, H. C. V. Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2015;2017(2):161\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2158_CR3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","volume":"385","author":"DP Webster","year":"2015","unstructured":"Webster DP, Klenerman P, Dusheiko GM. Hepatitis C. Lancet. 2015;385:1124\u201335.","journal-title":"Lancet"},{"key":"2158_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1665-2681(19)31786-7","volume":"8","author":"B Kronenberger","year":"2009","unstructured":"Kronenberger B, Zeuzem S. Current and future treatment options for HCV. Ann Hepatol. 2009;8:103\u201312.","journal-title":"Ann Hepatol"},{"key":"2158_CR5","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, Clinical Practice Guidelines Panel Chair, EASL Governing Board representative, Panel members. EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020;73:1170\u2013218.","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"2158_CR6","unstructured":"AbbVie. Maviret EU Summary of product characteristics. 2021. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/maviret-epar-product-information_en.pdf. Cited 04 Oct 2021"},{"key":"2158_CR7","unstructured":"AbbVie. Mavyret US Package Insert. 2021. https:\/\/www.rxabbvie.com\/pdf\/mavyret_pi.pdf. Cited 04 Oct 2021"},{"key":"2158_CR8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa1702417","volume":"378","author":"S Zeuzem","year":"2018","unstructured":"Zeuzem S, Foster GR, Wang S, et al. Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection. N Engl J Med. 2018;378:354\u201369.","journal-title":"N Engl J Med"},{"key":"2158_CR9","first-page":"441","volume":"72","author":"RS Brown Jr","year":"2020","unstructured":"Brown RS Jr, Buti M, Rodrigues L, et al. Glecaprevir\/pibrentasvir for 8weeks in treatment-naive patients with chronic HCV genotypes 1\u20136 and compensated cirrhosis: The EXPEDITION-8 trial. J Hepatol. 2020;72:441\u20139.","journal-title":"J Hepatol"},{"key":"2158_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cgh.2017.09.027","volume":"16","author":"T Asselah","year":"2018","unstructured":"Asselah T, Kowdley KV, Zadeikis N, et al. Efficacy of glecaprevir\/pibrentasvir for 8 or 12 weeks in patients with hepatitis C virus genotype 2, 4, 5, or 6 infection without cirrhosis. Clin Gastroenterol Hepatol. 2018;16:417\u201326.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2158_CR11","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s12325-020-01301-5","volume":"37","author":"SL Flamm","year":"2020","unstructured":"Flamm SL, Kort J, Marx SE, et al. Effectiveness of 8-week glecaprevir\/pibrentasvir for treatment-naive, compensated cirrhotic patients with chronic hepatitis C infection. Adv Ther. 2020;37:2267\u201374.","journal-title":"Adv Ther"},{"key":"2158_CR12","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/liv.14937","volume":"41","author":"H Klinker","year":"2021","unstructured":"Klinker H, Naumann U, Rossle M, et al. Glecaprevir\/pibrentasvir for 8 weeks in patients with compensated cirrhosis: safety and effectiveness data from the German Hepatitis C-Registry. Liver Int. 2021;41:1518\u201322.","journal-title":"Liver Int"},{"key":"2158_CR13","doi-asserted-by":"crossref","first-page":"954A","DOI":"10.1016\/j.jhep.2019.01.015","volume":"70","author":"P Lampertico","year":"2019","unstructured":"Lampertico P, Peck-Radosavljevic M, Bondin M, et al. Addressing barriers to hepatitis C virus (HCV) elimination: real-world outcomes in historically underserved patients with chronic HCV infection treated with glecaprevir\/pibrentasvir. Hepatology. 2019;70:954A-A955.","journal-title":"Hepatology"},{"key":"2158_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00455-1","author":"A Aghemo","year":"2021","unstructured":"Aghemo A, Horsmans Y, Bourgeois S, et al. Real-world outcomes in historically underserved patients with chronic hepatitis C infection treated with glecaprevir\/pibrentasvir. Infect Dis Ther. 2021. https:\/\/doi.org\/10.1007\/s40121-021-00455-1.","journal-title":"Infect Dis Ther"},{"key":"2158_CR15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jhep.2018.11.011","volume":"70","author":"R D'Ambrosio","year":"2019","unstructured":"D\u2019Ambrosio R, Pasulo L, Puoti M, et al. Real-world effectiveness and safety of glecaprevir\/pibrentasvir in 723 patients with chronic hepatitis C. J Hepatol. 2019;70:379\u201387.","journal-title":"J Hepatol"},{"key":"2158_CR16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"C Clopper","year":"1934","unstructured":"Clopper C, Pearson E. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404\u201313.","journal-title":"Biometrika"},{"key":"2158_CR17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13110","volume":"26","author":"D Back","year":"2019","unstructured":"Back D, Belperio P, Bondin M, et al. Efficacy and safety of glecaprevir\/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis. J Viral Hepat. 2019;26:951\u201360.","journal-title":"J Viral Hepat"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02158-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02158-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02158-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T19:03:05Z","timestamp":1656442985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02158-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2158"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02158-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}